1. Home
  2. IZEA vs GRCE Comparison

IZEA vs GRCE Comparison

Compare IZEA & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IZEA
  • GRCE
  • Stock Information
  • Founded
  • IZEA 2006
  • GRCE 2002
  • Country
  • IZEA United States
  • GRCE United States
  • Employees
  • IZEA N/A
  • GRCE N/A
  • Industry
  • IZEA Advertising
  • GRCE
  • Sector
  • IZEA Consumer Discretionary
  • GRCE
  • Exchange
  • IZEA Nasdaq
  • GRCE NYSE
  • Market Cap
  • IZEA 29.1M
  • GRCE 32.1M
  • IPO Year
  • IZEA N/A
  • GRCE N/A
  • Fundamental
  • Price
  • IZEA $1.95
  • GRCE $2.49
  • Analyst Decision
  • IZEA
  • GRCE Strong Buy
  • Analyst Count
  • IZEA 0
  • GRCE 1
  • Target Price
  • IZEA N/A
  • GRCE $12.00
  • AVG Volume (30 Days)
  • IZEA 30.2K
  • GRCE 22.0K
  • Earning Date
  • IZEA 05-14-2025
  • GRCE 05-15-2025
  • Dividend Yield
  • IZEA N/A
  • GRCE N/A
  • EPS Growth
  • IZEA N/A
  • GRCE N/A
  • EPS
  • IZEA N/A
  • GRCE N/A
  • Revenue
  • IZEA $35,881,010.00
  • GRCE N/A
  • Revenue This Year
  • IZEA $22.24
  • GRCE N/A
  • Revenue Next Year
  • IZEA N/A
  • GRCE N/A
  • P/E Ratio
  • IZEA N/A
  • GRCE N/A
  • Revenue Growth
  • IZEA N/A
  • GRCE N/A
  • 52 Week Low
  • IZEA $1.68
  • GRCE $1.75
  • 52 Week High
  • IZEA $3.60
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • IZEA 52.14
  • GRCE N/A
  • Support Level
  • IZEA $1.72
  • GRCE N/A
  • Resistance Level
  • IZEA $1.85
  • GRCE N/A
  • Average True Range (ATR)
  • IZEA 0.10
  • GRCE 0.00
  • MACD
  • IZEA 0.03
  • GRCE 0.00
  • Stochastic Oscillator
  • IZEA 94.74
  • GRCE 0.00

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: